COSCIENS Biopharma Total Liabilities

COSCIENS Biopharma (CSCI) currently reports a total liabilities of $4M as of June 2026. That compares with $20M in the prior-year period — down 80.4% year over year. Use the charts on this page to explore COSCIENS Biopharma's total liabilities history and peer comparisons.

COSCIENS Biopharma's total liabilities decreased from $20M to $4M — a 80.4% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

COSCIENS Biopharma reported $4M in total liabilities as of June 2026. That compares with $20M in the prior-year period — down 80.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $4M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for COSCIENS Biopharma, and consider following CSCI for alerts when major investors trade the stock.

COSCIENS Biopharma is classified in the Healthcare sector. On total liabilities, it currently shows $4M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CSCI with unrelated industries.